News & Analysis on Clinical Trial Services & Contract Research And Development
final update
The final results of the US FDA, EMA, TGA joint manufacturing facility inspection programme will make for interesting reading for API producers as they strongly hint the approach is here to stay.
DSM wants to form a CMO joint venture to become less reliant on big pharma clients and revive the flagging business unit.
Stellar Biotechnologies is supplying SAFC with an intermediate derived from limpets to support production of cancer vaccines.
Covance has announced it will collaborate on a genome sequencing project with Broad Institute to create genomic resources for a research model.
HP has launched a global authentication service it says will help identify counterfeit and stolen pharmaceuticals.
FMC plans to add controlled release technologies and expand excipient production to drive growth at its BioPolymer unit.
Contract services firm SeraCare Life Sciences are considering a sale in what it says is part of a major shake-up to drive shareholder value.